Get the latest tech news
VC megadeals are booming — and AI is surprisingly not the top category
Ask any VC if we’re still in a venture capital bear market and that investor will almost certainly tell you no, that funding is still flowing for good
For instance, Crunchbase calls out AI drug discovery company Xaira Therapeutics as one of the notable health tech megadeals. While it is also using machine learning to speed drug creation, its focus is finding medications for certain small molecule receptors on cell membranes. The deal was backed by classic tech investors Insight Partners and Gaingels, as well as NVentures (NVIDIA’s venture capital arm), which seems to be everywhere these days.
Or read this on TechCrunch
